Not a good buy right now: the trend is bearish (SMA_200 > SMA_20 > SMA_5) and momentum is still negative (MACD histogram below 0).
With no Intellectia buy signals today (AI Stock Picker and SwingMax both show no signal), there’s no strong timing edge for an impatient entry.
If you already own it, this is more of a hold/monitor near support (~80.98) rather than adding aggressively; a higher-probability buy setup would be a reclaim of the 86.39 pivot and improving momentum.
Momentum: MACD histogram at -0.352 (below zero) = bearish; “negatively contracting” suggests downside momentum may be easing but has not flipped bullish.
RSI(6): 37.95 = neutral-to-weak (not a clear oversold reversal signal).
Key levels: Current pre-market ~83.52 is below pivot 86.39 (bearish). Nearby support S1 ~80.98 (important near-term downside level); resistance starts at pivot 86.39 then R1 ~91.80.
Pattern-based forward view: Similar-pattern stats imply ~-0.39% next day, ~+0.24% next week, and ~-3.02% next month (tilts risk to the downside).
than resistance, so a short-term technical bounce is possible if support holds.
Neutral/Negative Catalysts
No recent news in the last week, meaning no clear event-driven catalyst to reverse the current bearish trend.
Bearish technical structure (below pivot, bearish MA stack, MACD still negative).
Trading trends are neutral (hedge funds and insiders show no significant recent activity), offering no “smart money” confirmation.
Statistical pattern outlook skews negative over the next month (~-3.02%).
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $83.523M, reported as up 0.00% YoY (flat growth).
Net income: $5.711M, reported as up 0.00% YoY (flat growth).
EPS: $0.13, reported as up 0.00% YoY (flat growth).
Gross margin: 69.94%, reported as up 0.00% YoY (stable).
Takeaway: financially stable with strong margins, but the provided data indicates no YoY acceleration in growth in the latest quarter.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so a Wall Street pros/cons trend assessment cannot be confirmed from this dataset.
With no rating/target momentum available, the decision leans more heavily on technicals and signals, which are currently not supportive for a fresh buy.
Wall Street analysts forecast BLLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BLLN is 137.83 USD with a low forecast of 110 USD and a high forecast of 160 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast BLLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BLLN is 137.83 USD with a low forecast of 110 USD and a high forecast of 160 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
